scispace - formally typeset
R

Rakel López de Maturana

Researcher at Netherlands Cancer Institute

Publications -  8
Citations -  323

Rakel López de Maturana is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: LRRK2 & Mutation. The author has an hindex of 7, co-authored 8 publications receiving 277 citations.

Papers
More filters
Journal ArticleDOI

The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.

TL;DR: Data suggest that the G2019S mutation induces autophagy via MEK/ERK pathway and that the inhibition of this exacerbated autophagic activity reduces the sensitivity observed in G 2019S mutant cells.
Journal ArticleDOI

Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons

TL;DR: The results show that LRRK2 mutations affect α-synuclein regulation and impair NF-κB canonical signaling in iPSC-derived neurons, strengthening the link between L RRK2 and the innate immunity system underscoring the involvement of inflammatory pathways in the neurodegenerative process in PD.
Journal ArticleDOI

Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.

TL;DR: Multiple defects in inflammatory pathways in which LRRK2 appears to be critically involved are described, including weak induction of pro-inflammatory cytokines and reduced NFκB transcriptional activation.
Journal ArticleDOI

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1

TL;DR: A novel role of PINK1 modulating the levels of L RRK2 in Parkinson’s disease fibroblasts and neurons is identified, a convergent pathway for these PARK genes is suggested, and the role of LRRK2 is broadened in the pathogenesis of Parkinson's disease.